FDA Panel Supports Removing Warnings on Menopause Hormone Therapy
TL;DR Summary
An FDA expert panel recommended removing the black box warning on menopausal hormone therapies, citing potential benefits and questioning the overemphasis on risks, which could lead to increased use of these treatments for menopausal women.
- FDA panel backs menopausal hormone therapy Axios
- F.D.A. Panelists Call for Removal of Warnings on Menopause Treatments The New York Times
- FDA chief: HRT warning among ‘greatest mistakes of modern medicine’ NewsNation
- FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women fda.gov
- US could scrap health warnings on HRT The Telegraph
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
3 min
vs 3 min read
Condensed
94%
590 → 35 words
Want the full story? Read the original article
Read on Axios